Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society.

Anticoagulation therapy Bleeding Cardiovascular diseases Contraceptive agents Neoplasms Pulmonary embolism Pulmonary hypertension Sports Thrombophilia Travel

Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
25 01 2022
Historique:
received: 02 12 2020
revised: 22 02 2021
accepted: 12 11 2021
pubmed: 8 12 2021
medline: 1 4 2022
entrez: 7 12 2021
Statut: ppublish

Résumé

This position paper provides a comprehensive guide for optimal follow-up of patients with acute pulmonary embolism (PE), covering multiple relevant aspects of patient counselling. It serves as a practical guide to treating patients with acute PE complementary to the formal 2019 European Society of Cardiology guidelines developed with the European Respiratory Society. We propose a holistic approach considering the whole spectrum of serious adverse events that patients with acute PE may encounter on the short and long run. We underline the relevance of assessment of modifiable risk factors for bleeding, of acquired thrombophilia and limited cancer screening (unprovoked PE) as well as a dedicated surveillance for the potential development of chronic thromboembolic pulmonary hypertension as part of routine practice; routine testing for genetic thrombophilia should be avoided. We advocate the use of outcome measures for functional outcome and quality of life to quantify the impact of the PE diagnosis and identify patients with the post-PE syndrome early. Counselling patients on maintaining a healthy lifestyle mitigates the risk of the post-PE syndrome and improves cardiovascular prognosis. Therefore, we consider it important to discuss when and how to resume sporting activities soon after diagnosing PE. Additional patient-relevant topics that require Focused counselling are travel and birth control.

Identifiants

pubmed: 34875048
pii: 6454843
doi: 10.1093/eurheartj/ehab816
pmc: PMC8790766
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-189

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Am J Respir Crit Care Med. 2010 Mar 1;181(5):501-6
pubmed: 19965808
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e005263
pubmed: 30571339
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):533-537
pubmed: 33275699
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2478-85
pubmed: 25212233
BMJ. 2017 Mar 17;356:j1065
pubmed: 28314711
BJOG. 2018 Nov;125(12):1581-1589
pubmed: 29940089
J Thromb Haemost. 2019 Apr;17(4):645-656
pubmed: 30690830
Blood. 2020 Mar 5;135(10):724-734
pubmed: 31951652
Cochrane Database Syst Rev. 2018 Nov 08;11:CD010837
pubmed: 30407621
Eur Respir J. 2017 Feb 23;49(2):
pubmed: 28232411
Circulation. 2008 Jan 1;117(1):93-102
pubmed: 18086925
Chest. 2016 Feb;149(2):315-352
pubmed: 26867832
Thromb Res. 2020 Jun;190:45-51
pubmed: 32298840
Thromb Haemost. 2014 Sep 2;112(3):598-605
pubmed: 24898545
Eur Respir Rev. 2019 Dec 18;28(154):
pubmed: 31852745
Semin Respir Crit Care Med. 2021 Apr;42(2):299-307
pubmed: 33548930
Angiology. 2002 Jan-Feb;53(1):1-6
pubmed: 11863301
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
Aviat Space Environ Med. 2012 Jul;83(7):673-6
pubmed: 22779310
Ann Intern Med. 2017 Sep 19;167(6):410-417
pubmed: 28828492
Cochrane Database Syst Rev. 2016 Sep 14;9:CD004002
pubmed: 27624857
Europace. 2021 Oct 9;23(10):1612-1676
pubmed: 33895845
Blood Adv. 2021 Feb 23;5(4):927-974
pubmed: 33570602
Blood. 2018 Sep 27;132(13):1365-1371
pubmed: 30002145
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545969
N Engl J Med. 1998 Apr 23;338(17):1169-73
pubmed: 9554856
J Thromb Haemost. 2020 Nov;18(11):2828-2839
pubmed: 33462974
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1444-1456
pubmed: 30219401
Intern Emerg Med. 2021 May 28;:
pubmed: 34047911
Eur Heart J. 2021 Nov 16;:
pubmed: 34791154
J Thromb Haemost. 2021 Jan;19(1):297-303
pubmed: 33405381
Thromb Res. 2020 Jul;191:97-102
pubmed: 32416310
J Thromb Haemost. 2021 Feb;19(2):531-535
pubmed: 33128325
Eur Heart J. 2021 Jan 1;42(1):17-96
pubmed: 32860412
Lancet. 2007 Nov 24;370(9601):1773-9
pubmed: 18037081
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):774-83
pubmed: 24608188
Ann Intern Med. 2019 Jun 4;170(11):756-763
pubmed: 31060047
Thromb Res. 2021 Jul;203:172-185
pubmed: 34029849
Circulation. 2020 Feb 4;141(5):376-386
pubmed: 31896275
J Thromb Haemost. 2020 Apr;18(4):926-930
pubmed: 31872492
Thromb Res. 2019 Sep;181 Suppl 1:S1-S5
pubmed: 31477219
Eur Respir J. 2016 Nov;48(5):1369-1376
pubmed: 27471209
J Thromb Haemost. 2018 Sep;16(9):1775-1778
pubmed: 29974611
JAMA Netw Open. 2020 Feb 5;3(2):e200064
pubmed: 32108888
Eur Heart J. 2013 Nov;34(41):3217-35
pubmed: 23900695
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
Br J Haematol. 2017 Apr;177(1):127-135
pubmed: 28106922
J Heart Lung Transplant. 2019 Jul;38(7):731-738
pubmed: 30962147
N Engl J Med. 2003 Apr 10;348(15):1435-41
pubmed: 12686699
J Thromb Haemost. 2006 Sep;4(9):1891-6
pubmed: 16961597
Blood Rev. 2014 Nov;28(6):221-6
pubmed: 25168205
Res Pract Thromb Haemost. 2020 Aug 02;4(6):958-968
pubmed: 32864549
J Thromb Haemost. 2018 Apr;16(4):809-813
pubmed: 29532986
Thorax. 2021 Oct;76(10):1002-1009
pubmed: 33758073
Circulation. 2019 Oct 29;140(18):1451-1459
pubmed: 31510769
Eur Respir J. 2021 Jun 17;57(6):
pubmed: 33334946
Respiration. 2016;91(6):503-9
pubmed: 27327769
Ann Intern Med. 2019 Nov 19;171(10):685-694
pubmed: 31610549
Blood. 2009 Aug 20;114(8):1484-8
pubmed: 19549987

Auteurs

Frederikus A Klok (FA)

Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Netherlands.
Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.

Walter Ageno (W)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Cihan Ay (C)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Magnus Bäck (M)

Center for Molecular Medicine and Department of Cardiology, Karolinska University Hospital, Solna, Sweden, Stockholm.
INSERM U1116, Université de Lorraine, Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre les Nancy, France.

Stefano Barco (S)

Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.
Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.

Laurent Bertoletti (L)

Service de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, Saint-Etienne 42055, France.
INSERM, UMR1059, Université Jean-Monnet, Saint-Etienne 42055, France.
INSERM, CIC-1408, CHU de Saint-Etienne, Saint-Etienne 42055, France.
INNOVTE, CHU de Saint-Etienne, Saint-Etienne 42055, France.

Cecilia Becattini (C)

Internal and Cardiovascular Medicine-Stroke Unit, University of Perugia, Perugia, Italy.

Jørn Carlsen (J)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Marion Delcroix (M)

Clinical Dept. of Respiratory Diseases, Pulmonary Hypertension Center, UZ Leuven, Leuven, Belgium.
BREATHE, Dept CHROMETA, KU Leuven, Leuven, Belgium.

Nick van Es (N)

Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, Netherlands.

Menno V Huisman (MV)

Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Netherlands.

Luis Jara-Palomares (L)

Medical Surgical Unit of Respiratory Diseases, Instituto de Biomedicina de Sevilla (IBiS). Hospital Universitario Virgen del Rocio, Seville, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.

Stavros Konstantinides (S)

Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.
Department of Cardiology, Democritus University of Thrace, Greece.

Irene Lang (I)

Department of Internal Medicine II, Cardiology and Center of Cardiovascular Medicine, Medical University of Vienna, Währinger Gürtel 18-20, Vienna 1090, Austria.

Guy Meyer (G)

Respiratory Medicine Department, Hôpital Européen Georges Pompidou, Aphp, Paris, France.
Université Paris Descartes, Paris 75006, France.

Fionnuala Ní Áinle (F)

Dept. of Hematology, Mater University Hospital and Rotunda Hospital, Dublin, Ireland.
School of Medicine, University College Dublin, Dublin, Ireland.

Stephan Rosenkranz (S)

Dept. of Cardiology, Heart Center at the University of Cologne, Germany.
Cologne Cardiovascular Research Center (CCRC), University of Cologne, Köln 50937, Germany.

Piotr Pruszczyk (P)

Dept. of Internal Medicine and Cardiology Medical University of Warsaw, Lindley St 4, Warsaw 00-005, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH